GGrantIndex
← Leaderboards

Stephen N. Gomperts

Massachusetts General Hospital

$8,663,513
Attributed
$10,831,896
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,831,896 · 8

By mechanism

R01$7,601,027 · 3
R21$941,875 · 2
K08$878,727 · 1
R56$776,355 · 1
R41$633,912 · 1

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposBrainCellsBehavioralFunctional DisorderS DiseaseParkinson DiseaseInsightResearch PersonnelImageDopamineResponseResourcesAnimalsHippocampus (Brain)Dopaminergic NeuronNeuronsInterdisciplinary StudyImpairmentPathologyAmyloid Beta-ProteinMidbrain StructurePropertyNeurosciences

Grant awards (24)

Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat$814,349
R01 · FY2025 · AG · contact PI
Neural Circuit Disruption in Freely-Behaving models of Alzheimer's Disease.$753,458
R01 · FY2025 · AG · contact PI
Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat$827,629
R01 · FY2024 · AG · contact PI
Neural Circuit Disruption in Freely-Behaving models of Alzheimer's Disease.$768,833
R01 · FY2024 · AG · contact PI
Imaging epigenetic dysregulation in the Lewy body dementias with [11C]Martinostat$821,147
R01 · FY2023 · AG · contact PI
Neural Circuit Disruption in Freely-Behaving models of Alzheimer's Disease.$768,833
R01 · FY2023 · AG · contact PI
Neural Circuit Disruption in Freely-Behaving models of Alzheimer's Disease.$765,473
R01 · FY2022 · AG · contact PI
HBI-002 to Treat Parkinson’s Disease$180,754
R41 · FY2022 · NS
Imaging Epigenetic Mechanisms in the Lewy Body Dementias with [11C]Martinostat$776,355
R56 · FY2021 · AG · contact PI
HBI-002 to Treat Parkinson’s Disease$453,158
R41 · FY2021 · NS
Impact of Amyloid Beta on Hippocampal Neurophysiology and Calcium Activity across the Sleep-Wake Cycle$416,261
R01 · FY2021 · AG · contact PI
Impact of Amyloid Beta on Hippocampal Neurophysiology and Calcium Activity across the Sleep-Wake Cycle$416,261
R01 · FY2020 · AG · contact PI
Impact of Amyloid Beta on Hippocampal Neurophysiology and Calcium Activity across the Sleep-Wake Cycle$416,261
R01 · FY2019 · AG · contact PI
Imaging Epigenetic Mechanisms in Parkinson's Disease with [11C]Martinostat$210,625
R21 · FY2019 · NS · contact PI
Impact of Amyloid Beta on Hippocampal Neurophysiology and Calcium Activity across the Sleep-Wake Cycle$416,261
R01 · FY2018 · AG · contact PI
Imaging Epigenetic Mechanisms in Parkinson's Disease with [11C]Martinostat$252,750
R21 · FY2018 · NS · contact PI
Impact of Amyloid Beta on Hippocampal Neurophysiology and Calcium Activity across the Sleep-Wake Cycle$416,261
R01 · FY2017 · AG · contact PI
PET imaging of hyperphosphorylated tau differentiates PSP and CBD from PD$217,500
R21 · FY2015 · NS · contact PI
PET imaging of hyperphosphorylated tau differentiates PSP and CBD from PD$261,000
R21 · FY2014 · NS · contact PI
Ventral Tegmental Area and Hippocampal Interactions in Reinforced Spatial Learnin$176,503
K08 · FY2012 · MH · contact PI
Ventral Tegmental Area and Hippocampal Interactions in Reinforced Spatial Learnin$180,889
K08 · FY2011 · MH · contact PI
Ventral Tegmental Area and Hippocampal Interactions in Reinforced Spatial Learnin$176,690
K08 · FY2010 · MH · contact PI
Ventral Tegmental Area and Hippocampal Interactions in Reinforced Spatial Learnin$174,005
K08 · FY2009 · MH · contact PI
Ventral Tegmental Area and Hippocampal Interactions in Reinforced Spatial Learnin$170,640
K08 · FY2008 · MH · contact PI